184 related articles for article (PubMed ID: 11903229)
61. The demonstration of SS-A/Ro antigen in human fetal tissues and in neonatal and adult skin.
Lee LA; Harmon CE; Huff JC; Norris DA; Weston WL
J Invest Dermatol; 1985 Aug; 85(2):143-6. PubMed ID: 3926904
[TBL] [Abstract][Full Text] [Related]
62. Subacute cutaneous lupus erythematosus.
David-Bajar KM
J Invest Dermatol; 1993 Jan; 100(1):2S-8S. PubMed ID: 8423385
[TBL] [Abstract][Full Text] [Related]
63. Fine specificity of anti-Ro(SSA) autoantibodies and clinical manifestations in patients with systemic lupus erythematosus.
Zimmermann C; Smolen JS; Graninger W; Petera P; Fabini G; Hassfeld W; Höfler E; Steiner G
J Rheumatol; 1996 Nov; 23(11):1897-903. PubMed ID: 8923363
[TBL] [Abstract][Full Text] [Related]
64. A characteristic cutaneous direct immunofluorescent pattern associated with Ro(SS-A) antibodies in subacute cutaneous lupus erythematosus.
Valeski JE; Kumar V; Forman AB; Beutner EH; Chorzelski TP
J Am Acad Dermatol; 1992 Aug; 27(2 Pt 1):194-8. PubMed ID: 1430355
[TBL] [Abstract][Full Text] [Related]
65. Ro60 and La ribonucleoproteins become self-aggregated by cell stress.
Sánchez-Rodríguez SH; Herrera-van Oostdam D; Avalos-Díaz E; Herrera-Esparza R
Reumatismo; 2007; 59(4):292-8. PubMed ID: 18157285
[TBL] [Abstract][Full Text] [Related]
66. Chilblain lupus erythematosus is associated with antibodies to SSA/Ro.
Franceschini F; Calzavara-Pinton P; Valsecchi L; Quinzanini M; Zane C; Facchetti F; Airò P; Cattaneo R
Adv Exp Med Biol; 1999; 455():167-71. PubMed ID: 10599339
[TBL] [Abstract][Full Text] [Related]
67. Detection of anti-Ro(SSA) antibodies by gel double diffusion and a 'sandwich' ELISA in systemic and subacute cutaneous lupus erythematosus and Sjögren's syndrome.
Provost TT; Levin LS; Watson RM; Mayo M; Ratrie H
J Autoimmun; 1991 Feb; 4(1):87-96. PubMed ID: 1903247
[TBL] [Abstract][Full Text] [Related]
68. 17-beta-estradiol increases expression of 52-kDa and 60-kDa SS-A/Ro autoantigens in human keratinocytes and breast cancer cell line MCF-7.
Wang D; Chan EK
J Invest Dermatol; 1996 Oct; 107(4):610-4. PubMed ID: 8823369
[TBL] [Abstract][Full Text] [Related]
69. The immune response to 52-kDa Ro and 60-kDa Ro is linked in experimental autoimmunity.
Keech CL; Gordon TP; McCluskey J
J Immunol; 1996 Oct; 157(8):3694-9. PubMed ID: 8871672
[TBL] [Abstract][Full Text] [Related]
70. Induction of anti-Ro60/anti-La by immunisation with spectrin and induction of anti-spectrin by immunisation with Ro60 and 4-hydroxy-2-nonenal-modified Ro60 immunisation.
Kurien BT; Dorri Y; Bachmann M; Scofield RH
Clin Exp Rheumatol; 2012; 30(6):886-93. PubMed ID: 22776429
[TBL] [Abstract][Full Text] [Related]
71. Ro ribonucleoprotein assembly in vitro. Identification of RNA-protein and protein-protein interactions.
Slobbe RL; Pluk W; van Venrooij WJ; Pruijn GJ
J Mol Biol; 1992 Sep; 227(2):361-6. PubMed ID: 1383550
[TBL] [Abstract][Full Text] [Related]
72. Protein heterogeneity in the human Ro/SSA ribonucleoproteins. The 52- and 60-kD Ro/SSA autoantigens are encoded by separate genes.
Itoh K; Itoh Y; Frank MB
J Clin Invest; 1991 Jan; 87(1):177-86. PubMed ID: 1985094
[TBL] [Abstract][Full Text] [Related]
73. Interaction of calcium and Ro60: increase of antigenicity.
Scofield RH; Kurien BT; Gross JK; Reed NB; Taylor AK; Dominguez N; Mehta P; Guthridge JM; Bachmann M
Mol Immunol; 2004 Jul; 41(8):809-16. PubMed ID: 15234560
[TBL] [Abstract][Full Text] [Related]
74. Latest update on the Ro/SS-A autoantibody system.
Schulte-Pelkum J; Fritzler M; Mahler M
Autoimmun Rev; 2009 Jun; 8(7):632-7. PubMed ID: 19393201
[TBL] [Abstract][Full Text] [Related]
75. Spreading of the immune response from 52 kDaRo and 60 kDaRo to calreticulin in experimental autoimmunity.
Kinoshita G; Keech CL; Sontheimer RD; Purcell A; McCluskey J; Gordon TP
Lupus; 1998; 7(1):7-11. PubMed ID: 9493142
[TBL] [Abstract][Full Text] [Related]
76. Characterization and genomic sequence of the murine 60 kD Ro gene.
Kaufman KM; Farris AD; Gross JK; Kirby MY; Harley JB
Genes Immun; 2000; 1(4):265-70. PubMed ID: 11196703
[TBL] [Abstract][Full Text] [Related]
77. Tyrosine kinase 2 and interferon regulatory factor 5 polymorphisms are associated with discoid and subacute cutaneous lupus erythematosus.
Järvinen TM; Hellquist A; Koskenmies S; Einarsdottir E; Koskinen LL; Jeskanen L; Berglind L; Panelius J; Hasan T; Ranki A; Kere J; Saarialho-Kere U
Exp Dermatol; 2010 Feb; 19(2):123-31. PubMed ID: 19758313
[TBL] [Abstract][Full Text] [Related]
78. An animal model of antibody binding in cutaneous lupus.
Lee LA; Weston WL; Krueger GG; Emam M; Reichlin M; Stevens JO; Surbrugg SK; Vasil A; Norris DA
Arthritis Rheum; 1986 Jun; 29(6):782-8. PubMed ID: 3521613
[TBL] [Abstract][Full Text] [Related]
79. Subacute cutaneous lupus erythematosus-immunogenetic associations.
Watson RM; Talwar P; Alexander E; Bias WB; Provost TT
J Autoimmun; 1991 Feb; 4(1):73-85. PubMed ID: 2031665
[TBL] [Abstract][Full Text] [Related]
80. Anti-p57: a novel association with neonatal lupus.
Maddison PJ; Lee L; Reichlin M; Sinclair A; Wasson C; Schemmer G; Reichlin M
Clin Exp Immunol; 1995 Jan; 99(1):42-8. PubMed ID: 7813108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
